drugset

drugset / Trial / NCT01293058

Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid Overdose

NCT01293058 ↗

Phase 2 Completed 100 enrolled Isfahan University of Medical Sciences

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine which route of administration is better for treatment of opioid overdosed patients

Timeline

Start: 2007-03
Primary completion: 2007-06
Completion: 2007-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Naloxone	Small molecule	0.4 mg	Intranasal

Indications